Back
Kiniksa Pharmaceuticals International PLC Vs. Madrigal Pharmaceuticals Industry Stock Comparison
Sell
39
KNSA
Kiniksa Pharmaceuticals International PLC
Last Price:
21.49
Seasonality Move:
29.58%
Buy
82
MDGL
Madrigal Pharmaceuticals
Last Price:
331.02
Seasonality Move:
31.67%
Sell
39
Kiniksa Pharmaceuticals International PLC (KNSA)
is a Sell
Is Kiniksa Pharmaceuticals International PLC a Buy, Sell or Hold?
- The current Kiniksa Pharmaceuticals International PLC [KNSA] share price is $22.48. The Score for KNSA is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
- KNSA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
82
Madrigal Pharmaceuticals (MDGL)
is a Buy
Is Madrigal Pharmaceuticals a Buy, Sell or Hold?
- The current Madrigal Pharmaceuticals [MDGL] share price is $319.58. The Score for MDGL is 82, which is 64% above its historic median score of 50, and infers lower risk than normal.
- MDGL is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
KNSA Stock Price Chart
What is Kiniksa Pharmaceuticals International PLC's stock price today?
-
The Kiniksa Pharmaceuticals International PLC share price today is $22.48
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KNSA is experiencing selling pressure, which indicates risk of future bearish movement.
MDGL Stock Price Chart
What is Madrigal Pharmaceuticals's stock price today?
-
The Madrigal Pharmaceuticals share price today is $319.58
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MDGL is experiencing buying pressure, which is a positive indicator for future bullish movement.
KNSA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.42 | Sell |
Relative Strength Index (14 RSI): | 33.3 | Sell |
Chaikin Money Flow: | -219473 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (23.82 - 26.82) | Sell |
Bollinger Bands (100): | (20.95 - 26.73) | Sell |
MDGL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 8.37 | Buy |
Relative Strength Index (14 RSI): | 85.5 | Buy |
Chaikin Money Flow: | 2945933 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (194.64 - 241.02) | Buy |
Bollinger Bands (100): | (221.59 - 279.03) | Buy |
KNSA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 25.01 | Sell |
20-day SMA: | 25.44 | Sell |
50-day SMA: | 25.41 | Sell |
200-day SMA: | 21.53 | Buy |
8-day EMA: | 24.26 | Sell |
20-day EMA: | 25.07 | Sell |
50-day EMA: | 24.99 | Sell |
200-day EMA: | 22.03 | Buy |
MDGL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 230.72 | Buy |
20-day SMA: | 219.8 | Buy |
50-day SMA: | 228.31 | Buy |
200-day SMA: | 241.11 | Buy |
8-day EMA: | 244.62 | Buy |
20-day EMA: | 228.06 | Buy |
50-day EMA: | 230.04 | Buy |
200-day EMA: | 234.49 | Buy |
Kiniksa Pharmaceuticals International PLC Earnings Growth & KNSA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.27 per share, and an increase next year of $0.91 per share.
Madrigal Pharmaceuticals Earnings Growth & MDGL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $4.12 per share, a decrease next quarter of $0.00 per share, a decrease this year of $4.19 per share, and an increase next year of $9.06 per share.
Kiniksa Pharmaceuticals International PLC Technical Analysis
Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Madrigal Pharmaceuticals Technical Analysis
Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |